Supramolecular hydrogels encapsulating bioengineered mesenchymal stem cells for ischemic therapy†
Abstract
We developed supramolecular hyaluronate (HA) hydrogels to encapsulate genetically engineered mesenchymal stem cells (MSCs) for the treatment of limb ischemia. In vivo angiogenic factors could be produced stably by the bioengineered MSCs (BMSCs) within the supramolecular hydrogels showing effective vascular repair and enhanced blood perfusion.
- This article is part of the themed collections: Editors' collection: Supramolecular Polymers and Editors’ collection: Supramolecular Chemistry